908 Devices Inc. Q1 2025: Revenue Surges 59%, Reports Net Income of $43.6M, Adjusted EBITDA Loss Narrows to $4.6M

Reuters
05-13
<a href="https://laohu8.com/S/MASS">908 Devices Inc.</a> Q1 2025: Revenue Surges 59%, Reports Net Income of $43.6M, Adjusted EBITDA Loss Narrows to $4.6M

908 Devices Inc. (Nasdaq: MASS) reported its financial results for the first quarter of 2025, showing a significant increase in revenue from continuing operations, which grew 59% compared to the prior year. This growth was primarily driven by an increase in product and service revenue. The company's net income attributable to common stockholders reached $43.6 million for the first quarter, a notable improvement from a net loss of $10.9 million in the corresponding prior year period. This increase in net income was largely influenced by a $56.6 million gain from the divestiture of its bioprocessing product portfolio, despite a loss from discontinued operations during the first two months of the quarter. Operating expenses rose to $16.6 million, up from $11.5 million in the previous year, influenced by a $2.5 million non-cash charge related to the change in fair value of contingent consideration liability and expenses from the RedWave Technology acquisition. The adjusted EBITDA showed a loss of $4.6 million, an improvement from a $5.3 million loss in the same period last year. The company holds cash, cash equivalents, and marketable securities totaling $124.3 million as of March 31, 2025, with no outstanding debt. For the full year 2025, 908 Devices maintains its revenue guidance from continuing operations at $53 million to $55 million, representing an 11% to 15% growth compared to 2024.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. 908 Devices Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20250513762831) on May 13, 2025, and is solely responsible for the information contained therein.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10